On evolutionary origin of cancer

Cancer Cell International

Volumn 5, Issue , 2005, Pages

  Lichtenstein, Anatoly V ^a  

^a Cancer Research Center   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CANCER RESEARCH; CARCINOGENESIS; CELL DAMAGE; CELL FUNCTION; CELL KILLING; CELL POPULATION; CELL PROTECTION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENETIC RISK; GENETIC SELECTION; GENETIC STABILITY; GENOMIC INSTABILITY; HETEROZYGOTE; HUMAN; MOLECULAR EVOLUTION; MUTAGENESIS; MUTANT; NONHUMAN; TUMOR GROWTH;

EID: 18144368921     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-5-5     Document Type: Article

References (59)

1. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3:401-410.
2. Bissell MJ, Radisky D: Putting tumours in context. Nature Rev Cancer 2001, 1:46-54.
3. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001, 264:169-184.
4. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001, 15:50-65.
5. Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3: 62-374.
6. Jacks T, Weinberg RA: Taking the study of cancer cell survival to a new dimension. Cell 2002, 111:923-925.
7. Liu X, Sun Y, Weinberg RA, Lodish HF: Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev 2001, 12:1-8.
8. Schmitt CA: Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nat Rev Cancer 2003, 3:286-295.
9. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van Den Eynde BJ: Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003, 9:1269-1274.
10. DePinho RA: The age of cancer. Nature 2000, 408:248-254.
11. Ponder BA: Cancer genetics. Nature 2001, 411: 36-341.
12. Liotta LA, Kohn EC: The microenvironment of the tumourhost interface. Nature 2001, 411:375-379.
13. Hendrix MJ, Seftor EA, Hess AR, Seftor RE: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003, 3:411-421.
14. Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004, 4:11-22.
15. Pollard JW: Opinion: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4: 1-78.
16. Perez-Losada J, Balmain A: Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003, 3:434-443.
17. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
18. Ameisen JC: On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 2002, 9:367-393.
19. Finora K: Common paraneoplastic syndromes. Clin Tech Small Anim Pract 2003, 18:123-126.
20. Kritchevsky SB, Wilcosky TC, Morris DL, Truong KN, Tyroler HA: Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 1991, 51: 198-3203.
21. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2002, 2:862-871.
22. Ou YC, Yang CR, Ho HC, Cheng CL, Kao YL, Su CK, Chiu KY, Chen WM: The symptoms of renal cell carcinoma related to patients' survival. J Chin Med Assoc 2003, 66:537-543.
23. Nunney L: Lineage selection and the evolution of multistage carcinogenesis. Proc R Soc Lond B Biol Sci 1999, 266:493-498.
24. Skulachev VP: Programmed death phenomena: from organelle to organism. Ann N Y Acad Sci 2002, 959:214-237.
25. Den Otter W, Koten JW: A 4-mutation model of carcinogenesis for tumour suppressor genes. Anticancer Res 1999, 19:4845-4852.
26. Loeb LA: A Mutator Phenotype in Cancer. Cancer Res 2001, 61:3230-3239.
27. Vijg J: Somatic mutations and aging: a re-evaluation. Mutat Res 2000, 447:117-135.
28. Tomlinson I, Sasieni P, Bodmer W: How many mutations in a cancer? Am J Pathol 2002, 160:755-758.
29. Peto R, Roe FJ, Lee PN, Levy L, Clack J: Cancer and ageing in mice and men. Br J Cancer 1975, 32:411-426.
30. Leroi AM, Koufopanou V, Burt A: Opinion: Cancer selection. Nat Rev Cancer 2003, 3:226-231.
31. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002, 2:331-341.
32. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993, 7:139-146.
33. Knudson AGJ: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820-823.
34. Holmgren L, Szeles A, Rajnavolgyi E, Folkman J, Klein G, Ernberg I, Falk KI: Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 1999, 93:3956-3963.
35. Simpson AJ: The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 1997, 71: b209-240.
36. Campisi J: Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 1997, 45:482-488.
37. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications. Cancer Res 2003, 63:1727.
38. Tomlinson IP, Novelli MR, Bodmer WF: The mutation rate and cancer. Proc Natl Acad Sci U S A 1996, 93:14800-14803.
39. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IM, Vogelstein B, Lengauer C: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A 2002, 99:16226-16231.
40. Frank SA, Nowak MA: Cell biology: Developmental predisposition to cancer. Nature 2003, 422:494.
41. Sporn MB, Suh N: Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2002, 2:537-543.
42. Kuick RD, Neel JV, Strahler JR, Chu EH, Bargal R, Fox DA, Hanash SM: Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis. Proc Natl Acad Sci U S A 1992, 89:7036-7040.
43. Aitken RJ, Koopman P, Lewis SEM: Seeds of concern. Nature 2004, 432:48-52.
44. Masters JR, Koberle B: Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 2003, 3: 17-525.
45. Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO: Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003, 301:643-646.
46. Tiemann-Boege I, Navidi W, Grewal R, Cohn D, Eskenazi B, Wyrobek AJ, Arnheim N: The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect. Proc Natl Acad Sci U S A 2002, 99:14952-14957.
47. Knudson AG: Hereditary predisposition to cancer. Ann N Y Acad Sci 1997, 833:58-67.
48. Frank SA: Genetic variation in cancer predisposition: mutational decay of a robust genetic control network. Proc Natl Acad Sci U S A 2004, 101:8061-8065.
49. Frank SA: Genetic predisposition to cancer - insights from population genetics. Nat Rev Genet 2004, 5:764-772.
50. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci U S A 1993, 90:10914-10921.
51. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR: A census of human cancer genes. Nat Rev Cancer 2004, 4:177-183.
52. Kirkwood TB, Austad SN: Why do we age? Nature 2000, 408:233-238.
53. Campisi J: Cancer and ageing: rival demons? Nat Rev Cancer 2003, 3:339-349.
54. Demant P: Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 2003, 4:721-734.
55. Peto J, Houlston RS: Genetics and the common cancers. Eur J Cancer 2001, 37 Suppl 8:S88-S96.
56. Hamilton WD: The genetical evolution of social behaviour. I and II. J Theor Biol 1964, 7:1-52.
57. Maynard-Smith J: Group selection and kin selection. Nature 1964, 201:1145-1147.
58. Camplejohn RS, Gilchrist R, Easton D, McKenzie-Edwards E, Barnes DM, Eccles DM, Ardern-Jones A, Hodgson SV, Duddy PM, Eeles RA: Apoptosis, ageing and cancer susceptibility. Br J Cancer 2003, 88:487-490.
59. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL: TGF-{beta} Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia. Science 2004, 303:848-851.